Acharya SK et al. A preliminary open trial on interferon stimulator (SNMC) derived from Glycyrrhiza glabra in the treatment of subacute hepatic failure. Ind J Med Res 98:75-8, 1993.
Arase Y et al. The long term efficacy of Glycyrrhizin in chronic hepatitis C patients. Cancer 79:1494-500, 1997.
Arase Y et al. The superiority of laparoscopic examination in predicting hepatocellular carcinoma after interferon therapy for chronic type C hepatitis. Dig Endosc J Pharmacol 10:613-20, 1997.
Baker H et al. Plasma vitamin B12 titres as indicators of disease severity and mortality of patients with alcoholic hepatitis. Alcohol Alcoholism 22(1):15, 1987.
Baetgen D. Results of the treatment of epidemic hepatitis in children with high doses of ascorbic acid in the years 1957 - 1958.] Medizinische Monatschrift 15:30-36, 1961 (in German).
Baur H, Staub H. Treatment of hepatitis with infusions of ascorbic acid: Comparison with other
therapies. Abstract. JAMA 156(5):565, 1954.
Bortolotti F et al. Effect of an orally administered thymic derivative, Thymodulin, in chronic type B hepatitis in children. Curr Ther Res 43: 67-72, 1988.
Buzzelli G et al. A pilot study on the liver protective effect of silybin-phosphattidylcholine complex (IdB1016) in chronic active hepatitis. Int J Clin Pharmacol Ther Toxicol 31:456-60, 1993.
Cabre E, Gassull MA. Polyunsaturated fatty acid deficiency in liver diseases: Pathophysiological and clinical significance. Nutrition 12 7/8, 1996.
Calleja HB, Brooks RH. Acute hepatitis treated with high doses of vitamin C. Ohio State Med J 56:821-3, 1960.
Campbell RE, Pruitt FW. Vitamin B12 in the treatment of viral hepatitis. Am J Med Sci 224:252, 1952.
Campbell RE, Pruitt FW. The effect of vitamin B12 and folic acid in the treatment of viral hepatitis. Am J Med Sci 229:8-15, 1955.
Cathcart, RF. The method of determining proper doses of vitamin C for the treatment of disease by titrating to bowel tolerance. J Orthomol Psychiatry 10:125-32, 1981.
Cathcart, RF. The third face of vitamin C. J Orthomol Med 7: 197-200, 1992.
Choline chloride in treatment of infectious hepatitis. Nutr Rev 4:127-8, 1946.
Deak G et al. Immunomodulator effect of Silymarin therapy in chronic alcoholic liver diseases. Orv Hetil 131:1291-2, 1990.
Eisenburg J. Treatment of chronic hepatitis B. Part 2: Effect of glycyrrhizinic acid on the course of illness. Fortschr Med 110:392-8, 1992.
Fujisawa K et al. Therapeutic effects of liver hydrolysate preparation on chronic hepatitis: A double blind, controlled study. Asian Med J 26:497-526, 1984.
Galli M et al. Attempt to treat acute type B hepatitis with an orally administered thymic extract (thymomodulin): Preliminary results. Drugs Exptl Clin Res 11: 665-9, 1985.
Hampton T. Grapefruit Compound Battles Hepatitis C. JAMA 2008;299(13):1532.
Jain ASC, Mukerji DP. Observations on the therapeutic value of intravenous B12 in infective hepatitis. J Indian Med Assoc 35:502-5, 1960.
Jenkins PJ et al. Use of polyunsaturated phosphatidyl choline in HBsAg negative chronic active hepatitis: Results of prospective double-blind controlled trial. Liver 2:77-81, 1982.
Klenner FR. Observations on the dose of administration of ascorbic acid when employed beyond the range of a vitamin in human pathology. J Appl Nutr 23(3&4):61-88, Winter, 1971.
Komar VI. [The blood level of cobalamin as an indicator of the functional status of the liver in jaundice of different etiologies.] Lab Delo (9):11-2, 1991.
Machlin LJ. Use and safe of elevated dosages of vitamin E in adults. Int J Vitam Nutr Res Suppl 30:56-68, 1989.
Magliulio E et al. Results of a double blind study on the effect of Silymarin in the treatment of acute viral hepatitis carried out at two medical centres. Med Kiln 73: 1060, 1978.
Marena C et al. Preliminary clinical development of silipide: A new complex of silybin in toxic liver disorders. Planta Medical 57(S2): A124-5, 1991.
Mascarella S et al. Therapeutic and antilipoperoxidant effects of silybin-phosphattidylcholine complex in chronic liver disease: Preliminary results. Curr Ther Res 53 (1):98-102, 1993.
Matsuyama Y, Morita T, Higuchi M, Tsujii T. The effect of taurine administration on patients with acute hepatitis, in K Kuriyama, RJ Huxtable, H Iwata, Eds. Sulfur Amino Acids: Biochemical and Clinical Aspects. New York, Alan R. Liss, Inc., 1983:461-8.
Morishige F, Murata A. Vitamin C for prophylaxis of viral hepatitis B in transfused patients. J Int Coll Prev Med 5(1):54-58, 1978.
Murata A. Virucidal activity of vitamin C: Vitamin C for prevention and treatment of viral diseases, in T Hasegawa, Ed. Proc First Intersectional Congress Int Assoc Microbiol Soc, Vol. 3. Tokyo U. Press, 1975:432-42.
Nasrallah SM, Galambos JT. Aminoacid therapy of alcoholic hepatitis. Lancet ii:1276-7, 1980.
Ohbayashi A et al. A study of effects of liver hydrolysate on hepatic circulation. J Therapy 54: 1582-5, 1972.
Piazza M et al. Effect of (+)-cyanidanol-3 in acute HAV, HBV and non-A, non-B viral hepatitis. Hepatology 3(1):45-9, 198.
Sanbe K et al. Treatment of liver disease - with particular reference to liver hydrolysates. Jap J Clin Exp Med 50:2665-76, 1973.
Schomerus H et al. (+)-Cyanidanol-3 in the treatment of acute viral hepatitis: A randomized controlled trial. Hepatology 4(2):331-5, 1984.
Singh RB, Niaz MA, Ghosh S, et al. Dietary intake and plasma levels of antioxidant vitamins in health and disease: A hospital-based case-control study. J Nutr Environ Med 5:235-42, 1995.
Suzuki H et al. Effetcs of glycyrrhizin on biochemical tests in patients with chronic hepatitis: Double blind trial. Asian Med J 26:423-38, 1984.
Suzuki H et al. Cianidanol therapy for HBs-antigen-positive chronic hepatitis: A multicentre, double-blind study. Liver 6:35, 1986.
Suzuki T, Kawase T, Harada T. Clinical study of vitamin E status in patients with chronic liver diseases. Nippon Shokakibyo Gakkai Zasshi 88(4):1066-73, 1991.
Thygarajan SP et al. Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus. Lancet II:764-6, 1988.
Vailati A et al. Randomized open study of the dose-effect relationship of a short course of IdB 1016 in patients with viral or alcoholic hepatitis. Fitoterapia 44 (3): 219-28, 1993.
Windsor JA, Wynne-Jones G. Halothane hepatitis and prompt resolution with methionine therapy: Case report. N Z Med J 101:502-3, 1988.
Yu SY et al. Chemoprevention trial of human hepatitis with selenium supplementation in China. Biol Trace Elem Res 21(1-2):15-22, 1989.
